May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Roles of Co-Stimulatory Molecules in the Development of Murine Allergic Conjunctivitis
Author Affiliations & Notes
  • T. Sumi
    Ophthalmology, Kochi Medical School, Nankoku, Japan
  • A. Fukushima
    Ophthalmology, Kochi Medical School, Nankoku, Japan
  • K. Fukuda
    Ophthalmology, Yamaguchi University, ube, Japan
  • N. Kumagai
    Ophthalmology, Yamaguchi University, ube, Japan
  • T. Nishida
    Ophthalmology, Yamaguchi University, ube, Japan
  • M. Azuma
    Immunology, Tokyo Medical and Dental University, Tokyo, Japan
  • H. Yagita
    Immunology, Juntendo University School of Medicine, Tokyo, Japan
  • H. Ueno
    Ophthalmology, Kochi Medical School, Nankoku, Japan
  • Footnotes
    Commercial Relationships T. Sumi, None; A. Fukushima, None; K. Fukuda, None; N. Kumagai, None; T. Nishida, None; M. Azuma, None; H. Yagita, None; H. Ueno, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5204. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Sumi, A. Fukushima, K. Fukuda, N. Kumagai, T. Nishida, M. Azuma, H. Yagita, H. Ueno; Roles of Co-Stimulatory Molecules in the Development of Murine Allergic Conjunctivitis. Invest. Ophthalmol. Vis. Sci. 2007;48(13):5204.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: We have demonstrated that Ag-specific T cells play a predominant role in the development of experimental allergic conjunctivitis (EC) in mice. Activation of T cells requires the signal from co-stimulatory molecules. Therefore, we aimed to investigate the roles of co-stimulatory molecules related to T-cell activation play in the development of EC.

Methods:: EC was induced in BALB/c mice by active immunization with ragweed (RW) and passive immunization by transfer of RW-primed splenocytes followed by RW challenge in eye drops. Twenty-four hours after the RW challenge, the conjunctivas were harvested for histological analysis to determine the conjunctival infiltrating eosinophil numbers. To investigate the involvement of co-stimulatory molecules, antibodies (Abs) against co-stimulatory molecules (4-1BB, 4-1BB ligand (L), OX40, OX40L, inducible costimulator (ICOS), B7-related protein 1 (B7RP-1), programmed death-1 (PD-1), PD-L1, PD-L2, B7-1, B7-2 and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4)) were injected into EC-developing mice either during the induction or the effector phase.

Results:: During the induction phase, treatment with anti-4-1BB Ab, anti-OX40L Ab or combination of anti-B7-1 and anti-B7-2 Abs suppressed EC, while anti-OX40 Ab or anti-CTLA-4 Ab treatment augmented EC. During the effector phase, treatment with anti-4-1BB Ab, anti-PD-L2 Ab or anti-B7-2 Ab suppressed EC. Treatment with other Abs as described above did not significantly affect EC.

Conclusions:: These results demonstrated that each co-stimulatory molecule differently participates in the development of EC. In addition, co-stimulatory molecules within TNF-receptor family molecules play more significant roles than those within B7 family molecules, although treatment with Abs against co-stimulatory molecules of each family significantly affected systemic immune responses.

Keywords: conjunctivitis • immunomodulation/immunoregulation • pathology: experimental 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×